> top > docs > PubMed:18457324 > annotations

PubMed:18457324 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-207 Sentence denotes Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer.
T2 208-219 Sentence denotes BACKGROUND:
T3 220-348 Sentence denotes Exposure to anthracyclines as part of cancer therapy has been associated with the development of congestive heart failure (CHF).
T4 349-443 Sentence denotes The potential role of genetic risk factors in anthracycline-related CHF remains to be defined.
T5 444-779 Sentence denotes Thus, in this study, the authors examined whether common polymorphisms in candidate genes involved in the pharmacodynamics of anthracyclines (in particular, the nicotinamide adenine dinucleotide phosphate:quinone oxidoreductase 1 gene NQO1 and the carbonyl reductase 3 gene CBR3) had an impact on the risk of anthracycline-related CHF.
T6 780-788 Sentence denotes METHODS:
T7 789-977 Sentence denotes A nested case-control study was conducted within a cohort of 1979 patients enrolled in the Childhood Cancer Survivor Study who received treatment with anthracyclines and had available DNA.
T8 978-1172 Sentence denotes Thirty patients with CHF (cases) and 115 matched controls were genotyped for polymorphisms in NQO1 (NQO1*2) and CBR3 (the CBR3 valine [V] to methionine [M] substitution at position 244 [V244M]).
T9 1173-1375 Sentence denotes Enzyme activity assays with recombinant CBR3 isoforms (CBR3 V244 and CBR3 M244) and the anthracycline substrate doxorubicin were used to investigate the functional impact of the CBR3 V244M polymorphism.
T10 1376-1384 Sentence denotes RESULTS:
T11 1385-1578 Sentence denotes Multivariate analyses adjusted for sex and primary disease recurrence were used to test for associations between the candidate genetic polymorphisms (NQO1*2 and CBR3 V244M) and the risk of CHF.
T12 1579-1718 Sentence denotes Analyses indicated no association between the NQO1*2 polymorphism and the risk of anthracycline-related CHF (odds ratio [OR], 1.04; P=.97).
T13 1719-1882 Sentence denotes There was a trend toward an association between the CBR3 V244M polymorphism and the risk of CHF (OR, 8.16; P=.056 for G/G vs A/A; OR, 5.44; P=.092 for G/A vs A/A).
T14 1883-2105 Sentence denotes In line, recombinant CBR3 V244 (G allele) synthesized 2.6-fold more cardiotoxic doxorubicinol per unit of time than CBR3 M244 (A allele; CBR3 V244 [8.26+/-3.57 nmol/hour.mg] vs CBR3 M244 [3.22+/-0.67 nmol/hour.mg]; P=.01).
T15 2106-2118 Sentence denotes CONCLUSIONS:
T16 2119-2341 Sentence denotes The functional CBR3 V244M polymorphism may have an impact on the risk of anthracycline-related CHF among childhood cancer survivors by modulating the intracardiac formation of cardiotoxic anthracycline alcohol metabolites.
T17 2342-2397 Sentence denotes Larger confirmatory case-control studies are warranted.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
5009 29-49 GeneOrGeneProduct denotes carbonyl reductase 3 NCBIGene:874
5010 55-59 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5011 68-100 GeneOrGeneProduct denotes NAD(P)H:quinone oxidoreductase 1 NCBIGene:1728
5012 106-110 GeneOrGeneProduct denotes NQO1 NCBIGene:1728
5013 114-122 OrganismTaxon denotes patients NCBITaxon:9606
5014 137-150 ChemicalEntity denotes anthracycline MESH:D018943
5015 159-183 DiseaseOrPhenotypicFeature denotes congestive heart failure MESH:D006333
5016 200-206 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
5017 232-246 ChemicalEntity denotes anthracyclines MESH:D018943
5018 258-264 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
5019 317-341 DiseaseOrPhenotypicFeature denotes congestive heart failure MESH:D006333
5020 343-346 DiseaseOrPhenotypicFeature denotes CHF MESH:D006333
5021 395-408 ChemicalEntity denotes anthracycline MESH:D018943
5022 417-420 DiseaseOrPhenotypicFeature denotes CHF MESH:D006333
5023 570-584 ChemicalEntity denotes anthracyclines MESH:D018943
5024 605-673 GeneOrGeneProduct denotes nicotinamide adenine dinucleotide phosphate:quinone oxidoreductase 1 NCBIGene:1728
5025 679-683 GeneOrGeneProduct denotes NQO1 NCBIGene:1728
5026 692-712 GeneOrGeneProduct denotes carbonyl reductase 3 NCBIGene:874
5027 718-722 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5028 753-766 ChemicalEntity denotes anthracycline MESH:D018943
5029 775-778 DiseaseOrPhenotypicFeature denotes CHF MESH:D006333
5030 855-863 OrganismTaxon denotes patients NCBITaxon:9606
5031 940-954 ChemicalEntity denotes anthracyclines MESH:D018943
5032 985-993 OrganismTaxon denotes patients NCBITaxon:9606
5033 999-1002 DiseaseOrPhenotypicFeature denotes CHF MESH:D006333
5034 1072-1076 GeneOrGeneProduct denotes NQO1 NCBIGene:1728
5035 1078-1082 GeneOrGeneProduct denotes NQO1 NCBIGene:1728
5036 1090-1094 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5037 1100-1104 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5038 1105-1162 SequenceVariant denotes valine [V] to methionine [M] substitution at position 244 DBSNP:rs1056892
5039 1164-1169 SequenceVariant denotes V244M DBSNP:rs1056892
5040 1213-1217 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5041 1228-1232 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5042 1233-1237 SequenceVariant denotes V244 DBSNP:rs1056892
5043 1242-1246 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5044 1247-1251 SequenceVariant denotes M244 DBSNP:rs1056892
5045 1261-1274 ChemicalEntity denotes anthracycline MESH:D018943
5046 1285-1296 ChemicalEntity denotes doxorubicin MESH:D004317
5047 1351-1355 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5048 1356-1361 SequenceVariant denotes V244M DBSNP:rs1056892
5049 1535-1539 GeneOrGeneProduct denotes NQO1 NCBIGene:1728
5050 1546-1550 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5051 1551-1556 SequenceVariant denotes V244M DBSNP:rs1056892
5052 1574-1577 DiseaseOrPhenotypicFeature denotes CHF MESH:D006333
5053 1625-1629 GeneOrGeneProduct denotes NQO1 NCBIGene:1728
5054 1661-1674 ChemicalEntity denotes anthracycline MESH:D018943
5055 1683-1686 DiseaseOrPhenotypicFeature denotes CHF MESH:D006333
5056 1771-1775 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5057 1776-1781 SequenceVariant denotes V244M DBSNP:rs1056892
5058 1811-1814 DiseaseOrPhenotypicFeature denotes CHF MESH:D006333
5059 1904-1908 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5060 1909-1913 SequenceVariant denotes V244 DBSNP:rs1056892
5061 1951-1962 DiseaseOrPhenotypicFeature denotes cardiotoxic MESH:D066126
5062 1963-1976 ChemicalEntity denotes doxorubicinol MESH:C010013
5063 1999-2003 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5064 2004-2008 SequenceVariant denotes M244 DBSNP:rs1056892
5065 2020-2024 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5066 2025-2029 SequenceVariant denotes V244 DBSNP:rs1056892
5067 2060-2064 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5068 2065-2069 SequenceVariant denotes M244 DBSNP:rs1056892
5069 2134-2138 GeneOrGeneProduct denotes CBR3 NCBIGene:874
5070 2139-2144 SequenceVariant denotes V244M DBSNP:rs1056892
5071 2192-2205 ChemicalEntity denotes anthracycline MESH:D018943
5072 2214-2217 DiseaseOrPhenotypicFeature denotes CHF MESH:D006333
5073 2234-2240 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
5074 2295-2306 DiseaseOrPhenotypicFeature denotes cardiotoxic MESH:D066126
5075 2307-2328 ChemicalEntity denotes anthracycline alcohol MESH:D000438|MESH:D018943

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 159-183 DiseaseOrPhenotypicFeature denotes congestive heart failure 0005009
T2 170-183 DiseaseOrPhenotypicFeature denotes heart failure 0005252
T3 200-206 DiseaseOrPhenotypicFeature denotes cancer 0004992
T4 258-264 DiseaseOrPhenotypicFeature denotes cancer 0004992
T5 317-341 DiseaseOrPhenotypicFeature denotes congestive heart failure 0005009
T6 328-341 DiseaseOrPhenotypicFeature denotes heart failure 0005252
T7 890-896 DiseaseOrPhenotypicFeature denotes Cancer 0004992
T8 2234-2240 DiseaseOrPhenotypicFeature denotes cancer 0004992

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T1 1164-1169 SequenceVariant denotes V244M
T2 1356-1361 SequenceVariant denotes V244M
T3 1551-1556 SequenceVariant denotes V244M
T4 1776-1781 SequenceVariant denotes V244M
T5 2139-2144 SequenceVariant denotes V244M

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 29-49 GeneOrGeneProduct denotes carbonyl reductase 3
T2 55-59 GeneOrGeneProduct denotes CBR3
T3 68-100 GeneOrGeneProduct denotes NAD(P)H:quinone oxidoreductase 1
T4 106-110 GeneOrGeneProduct denotes NQO1
T5 170-175 GeneOrGeneProduct denotes heart
T6 328-333 GeneOrGeneProduct denotes heart
T7 657-671 GeneOrGeneProduct denotes oxidoreductase
T8 679-683 GeneOrGeneProduct denotes NQO1
T9 692-712 GeneOrGeneProduct denotes carbonyl reductase 3
T10 718-722 GeneOrGeneProduct denotes CBR3
T11 731-737 GeneOrGeneProduct denotes impact
T12 791-797 GeneOrGeneProduct denotes nested
T13 1072-1076 GeneOrGeneProduct denotes NQO1
T14 1078-1082 GeneOrGeneProduct denotes NQO1
T15 1090-1094 GeneOrGeneProduct denotes CBR3
T16 1100-1104 GeneOrGeneProduct denotes CBR3
T17 1173-1179 GeneOrGeneProduct denotes Enzyme
T18 1213-1217 GeneOrGeneProduct denotes CBR3
T19 1228-1232 GeneOrGeneProduct denotes CBR3
T20 1242-1246 GeneOrGeneProduct denotes CBR3
T21 1337-1343 GeneOrGeneProduct denotes impact
T22 1351-1355 GeneOrGeneProduct denotes CBR3
T23 1535-1539 GeneOrGeneProduct denotes NQO1
T24 1546-1550 GeneOrGeneProduct denotes CBR3
T25 1625-1629 GeneOrGeneProduct denotes NQO1
T26 1771-1775 GeneOrGeneProduct denotes CBR3
T27 1904-1908 GeneOrGeneProduct denotes CBR3
T28 1941-1945 GeneOrGeneProduct denotes fold
T29 1999-2003 GeneOrGeneProduct denotes CBR3
T30 2020-2024 GeneOrGeneProduct denotes CBR3
T31 2060-2064 GeneOrGeneProduct denotes CBR3
T32 2134-2138 GeneOrGeneProduct denotes CBR3
T33 2170-2176 GeneOrGeneProduct denotes impact
T34 2321-2328 GeneOrGeneProduct denotes alcohol

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 29-49 GeneOrGeneProduct denotes carbonyl reductase 3
T2 55-59 GeneOrGeneProduct denotes CBR3
T3 68-100 GeneOrGeneProduct denotes NAD(P)H:quinone oxidoreductase 1
T4 106-110 GeneOrGeneProduct denotes NQO1
T5 159-169 GeneOrGeneProduct denotes congestive
T6 170-175 GeneOrGeneProduct denotes heart
T7 250-254 GeneOrGeneProduct denotes part
T8 317-327 GeneOrGeneProduct denotes congestive
T9 328-333 GeneOrGeneProduct denotes heart
T10 384-391 GeneOrGeneProduct denotes factors
T11 657-671 GeneOrGeneProduct denotes oxidoreductase
T12 679-683 GeneOrGeneProduct denotes NQO1
T13 692-712 GeneOrGeneProduct denotes carbonyl reductase 3
T14 718-722 GeneOrGeneProduct denotes CBR3
T15 731-737 GeneOrGeneProduct denotes impact
T16 780-787 GeneOrGeneProduct denotes METHODS
T17 791-797 GeneOrGeneProduct denotes nested
T18 798-802 GeneOrGeneProduct denotes case
T19 963-972 GeneOrGeneProduct denotes available
T20 1004-1009 GeneOrGeneProduct denotes cases
T21 1072-1076 GeneOrGeneProduct denotes NQO1
T22 1078-1082 GeneOrGeneProduct denotes NQO1
T23 1090-1094 GeneOrGeneProduct denotes CBR3
T24 1100-1104 GeneOrGeneProduct denotes CBR3
T25 1173-1179 GeneOrGeneProduct denotes Enzyme
T26 1180-1188 GeneOrGeneProduct denotes activity
T27 1201-1212 GeneOrGeneProduct denotes recombinant
T28 1213-1217 GeneOrGeneProduct denotes CBR3
T29 1228-1232 GeneOrGeneProduct denotes CBR3
T30 1242-1246 GeneOrGeneProduct denotes CBR3
T31 1337-1343 GeneOrGeneProduct denotes impact
T32 1351-1355 GeneOrGeneProduct denotes CBR3
T33 1468-1472 GeneOrGeneProduct denotes test
T34 1535-1539 GeneOrGeneProduct denotes NQO1
T35 1546-1550 GeneOrGeneProduct denotes CBR3
T36 1625-1629 GeneOrGeneProduct denotes NQO1
T37 1771-1775 GeneOrGeneProduct denotes CBR3
T38 1826-1832 GeneOrGeneProduct denotes P=.056
T39 1846-1851 GeneOrGeneProduct denotes A; OR
T40 1859-1865 GeneOrGeneProduct denotes P=.092
T41 1886-1890 GeneOrGeneProduct denotes line
T42 1892-1903 GeneOrGeneProduct denotes recombinant
T43 1904-1908 GeneOrGeneProduct denotes CBR3
T44 1941-1945 GeneOrGeneProduct denotes fold
T45 1977-1980 GeneOrGeneProduct denotes per
T46 1989-1993 GeneOrGeneProduct denotes time
T47 1999-2003 GeneOrGeneProduct denotes CBR3
T48 2020-2024 GeneOrGeneProduct denotes CBR3
T49 2060-2064 GeneOrGeneProduct denotes CBR3
T50 2134-2138 GeneOrGeneProduct denotes CBR3
T51 2170-2176 GeneOrGeneProduct denotes impact
T52 2282-2291 GeneOrGeneProduct denotes formation
T53 2321-2328 GeneOrGeneProduct denotes alcohol
T54 2362-2366 GeneOrGeneProduct denotes case

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 159-183 DiseaseOrPhenotypicFeature denotes congestive heart failure D006333
T2 200-206 DiseaseOrPhenotypicFeature denotes cancer D009369
T3 258-264 DiseaseOrPhenotypicFeature denotes cancer D009369
T4 317-341 DiseaseOrPhenotypicFeature denotes congestive heart failure D006333
T5 343-346 DiseaseOrPhenotypicFeature denotes CHF D006333
T6 417-420 DiseaseOrPhenotypicFeature denotes CHF D006333
T7 775-778 DiseaseOrPhenotypicFeature denotes CHF D006333
T8 890-896 DiseaseOrPhenotypicFeature denotes Cancer D009369
T9 999-1002 DiseaseOrPhenotypicFeature denotes CHF D006333
T10 1436-1443 DiseaseOrPhenotypicFeature denotes disease D004194
T11 1444-1454 DiseaseOrPhenotypicFeature denotes recurrence D012008
T12 1574-1577 DiseaseOrPhenotypicFeature denotes CHF D006333
T13 1683-1686 DiseaseOrPhenotypicFeature denotes CHF D006333
T14 1811-1814 DiseaseOrPhenotypicFeature denotes CHF D006333
T15 1951-1962 DiseaseOrPhenotypicFeature denotes cardiotoxic D066126
T16 2214-2217 DiseaseOrPhenotypicFeature denotes CHF D006333
T17 2234-2240 DiseaseOrPhenotypicFeature denotes cancer D009369
T18 2295-2306 DiseaseOrPhenotypicFeature denotes cardiotoxic D066126
T19 2321-2328 DiseaseOrPhenotypicFeature denotes alcohol D000437

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 29-49 GeneOrGeneProduct denotes carbonyl reductase 3
T2 55-59 GeneOrGeneProduct denotes CBR3
T3 68-100 GeneOrGeneProduct denotes NAD(P)H:quinone oxidoreductase 1
T4 106-110 GeneOrGeneProduct denotes NQO1
T5 657-671 GeneOrGeneProduct denotes oxidoreductase
T6 679-683 GeneOrGeneProduct denotes NQO1
T7 692-712 GeneOrGeneProduct denotes carbonyl reductase 3
T8 718-722 GeneOrGeneProduct denotes CBR3
T9 1072-1076 GeneOrGeneProduct denotes NQO1
T10 1078-1082 GeneOrGeneProduct denotes NQO1
T11 1090-1094 GeneOrGeneProduct denotes CBR3
T12 1100-1104 GeneOrGeneProduct denotes CBR3
T13 1213-1217 GeneOrGeneProduct denotes CBR3
T14 1228-1232 GeneOrGeneProduct denotes CBR3
T15 1242-1246 GeneOrGeneProduct denotes CBR3
T16 1351-1355 GeneOrGeneProduct denotes CBR3
T17 1535-1539 GeneOrGeneProduct denotes NQO1
T18 1546-1550 GeneOrGeneProduct denotes CBR3
T19 1625-1629 GeneOrGeneProduct denotes NQO1
T20 1771-1775 GeneOrGeneProduct denotes CBR3
T21 1904-1908 GeneOrGeneProduct denotes CBR3
T22 1999-2003 GeneOrGeneProduct denotes CBR3
T23 2020-2024 GeneOrGeneProduct denotes CBR3
T24 2060-2064 GeneOrGeneProduct denotes CBR3
T25 2134-2138 GeneOrGeneProduct denotes CBR3

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 68-71 DiseaseOrPhenotypicFeature denotes NAD 0009755
T2 159-183 DiseaseOrPhenotypicFeature denotes congestive heart failure 0005009
T3 190-206 DiseaseOrPhenotypicFeature denotes childhood cancer 0006517
T4 317-341 DiseaseOrPhenotypicFeature denotes congestive heart failure 0005009
T5 343-346 DiseaseOrPhenotypicFeature denotes CHF 0005009
T6 417-420 DiseaseOrPhenotypicFeature denotes CHF 0005009
T7 775-778 DiseaseOrPhenotypicFeature denotes CHF 0005009
T8 880-896 DiseaseOrPhenotypicFeature denotes Childhood Cancer 0006517
T9 999-1002 DiseaseOrPhenotypicFeature denotes CHF 0005009
T10 1574-1577 DiseaseOrPhenotypicFeature denotes CHF 0005009
T11 1683-1686 DiseaseOrPhenotypicFeature denotes CHF 0005009
T12 1811-1814 DiseaseOrPhenotypicFeature denotes CHF 0005009
T13 2214-2217 DiseaseOrPhenotypicFeature denotes CHF 0005009
T14 2224-2240 DiseaseOrPhenotypicFeature denotes childhood cancer 0006517

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 159-183 DiseaseOrPhenotypicFeature denotes congestive heart failure D006333
T2 200-206 DiseaseOrPhenotypicFeature denotes cancer D009369
T3 258-264 DiseaseOrPhenotypicFeature denotes cancer D009369
T4 317-341 DiseaseOrPhenotypicFeature denotes congestive heart failure D006333
T5 343-346 DiseaseOrPhenotypicFeature denotes CHF D006333
T6 417-420 DiseaseOrPhenotypicFeature denotes CHF D006333
T7 775-778 DiseaseOrPhenotypicFeature denotes CHF D006333
T8 890-896 DiseaseOrPhenotypicFeature denotes Cancer D009369
T9 999-1002 DiseaseOrPhenotypicFeature denotes CHF D006333
T10 1436-1443 DiseaseOrPhenotypicFeature denotes disease D004194
T11 1444-1454 DiseaseOrPhenotypicFeature denotes recurrence D012008
T12 1574-1577 DiseaseOrPhenotypicFeature denotes CHF D006333
T13 1683-1686 DiseaseOrPhenotypicFeature denotes CHF D006333
T14 1811-1814 DiseaseOrPhenotypicFeature denotes CHF D006333
T15 1951-1962 DiseaseOrPhenotypicFeature denotes cardiotoxic D066126
T16 2214-2217 DiseaseOrPhenotypicFeature denotes CHF D006333
T17 2234-2240 DiseaseOrPhenotypicFeature denotes cancer D009369
T18 2295-2306 DiseaseOrPhenotypicFeature denotes cardiotoxic D066126

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 159-183 DiseaseOrPhenotypicFeature denotes congestive heart failure D006333
T2 200-206 DiseaseOrPhenotypicFeature denotes cancer D009369
T3 258-264 DiseaseOrPhenotypicFeature denotes cancer D009369
T4 317-341 DiseaseOrPhenotypicFeature denotes congestive heart failure D006333
T5 343-346 DiseaseOrPhenotypicFeature denotes CHF D006333
T6 417-420 DiseaseOrPhenotypicFeature denotes CHF D006333
T7 775-778 DiseaseOrPhenotypicFeature denotes CHF D006333
T8 890-896 DiseaseOrPhenotypicFeature denotes Cancer D009369
T9 999-1002 DiseaseOrPhenotypicFeature denotes CHF D006333
T10 1574-1577 DiseaseOrPhenotypicFeature denotes CHF D006333
T11 1683-1686 DiseaseOrPhenotypicFeature denotes CHF D006333
T12 1811-1814 DiseaseOrPhenotypicFeature denotes CHF D006333
T13 1951-1962 DiseaseOrPhenotypicFeature denotes cardiotoxic D066126
T14 2214-2217 DiseaseOrPhenotypicFeature denotes CHF D006333
T15 2234-2240 DiseaseOrPhenotypicFeature denotes cancer D009369
T16 2295-2306 DiseaseOrPhenotypicFeature denotes cardiotoxic D066126

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 29-47 ChemicalEntity denotes carbonyl reductase D000429
T2 68-74 ChemicalEntity denotes NAD(P) http://purl.obolibrary.org/obo/CHEBI_25524
T3 84-98 ChemicalEntity denotes oxidoreductase D010088
T4 137-150 ChemicalEntity denotes anthracycline D018943|http://purl.obolibrary.org/obo/CHEBI_48120
T6 232-246 ChemicalEntity denotes anthracyclines D018943|http://purl.obolibrary.org/obo/CHEBI_49322|http://purl.obolibrary.org/obo/CHEBI_48120
T9 395-408 ChemicalEntity denotes anthracycline D018943|http://purl.obolibrary.org/obo/CHEBI_48120
T11 570-584 ChemicalEntity denotes anthracyclines D018943|http://purl.obolibrary.org/obo/CHEBI_49322|http://purl.obolibrary.org/obo/CHEBI_48120
T14 605-617 ChemicalEntity denotes nicotinamide D009536|http://purl.obolibrary.org/obo/CHEBI_17154
T16 618-625 ChemicalEntity denotes adenine D000225|http://purl.obolibrary.org/obo/CHEBI_16708
T18 657-671 ChemicalEntity denotes oxidoreductase D010088
T19 692-710 ChemicalEntity denotes carbonyl reductase D000429
T20 753-766 ChemicalEntity denotes anthracycline D018943|http://purl.obolibrary.org/obo/CHEBI_48120
T22 940-954 ChemicalEntity denotes anthracyclines D018943|http://purl.obolibrary.org/obo/CHEBI_49322|http://purl.obolibrary.org/obo/CHEBI_48120
T25 1105-1111 ChemicalEntity denotes valine http://purl.obolibrary.org/obo/CHEBI_27266
T26 1119-1129 ChemicalEntity denotes methionine http://purl.obolibrary.org/obo/CHEBI_64558|http://purl.obolibrary.org/obo/CHEBI_16811
T28 1261-1274 ChemicalEntity denotes anthracycline D018943|http://purl.obolibrary.org/obo/CHEBI_48120
T30 1285-1296 ChemicalEntity denotes doxorubicin D004317|http://purl.obolibrary.org/obo/CHEBI_64816|http://purl.obolibrary.org/obo/CHEBI_28748
T33 1661-1674 ChemicalEntity denotes anthracycline D018943|http://purl.obolibrary.org/obo/CHEBI_48120
T35 1963-1976 ChemicalEntity denotes doxorubicinol C010013|http://purl.obolibrary.org/obo/CHEBI_133817
T37 2192-2205 ChemicalEntity denotes anthracycline D018943|http://purl.obolibrary.org/obo/CHEBI_48120
T39 2307-2320 ChemicalEntity denotes anthracycline D018943|http://purl.obolibrary.org/obo/CHEBI_48120
T41 2321-2328 ChemicalEntity denotes alcohol http://purl.obolibrary.org/obo/CHEBI_30879|http://purl.obolibrary.org/obo/CHEBI_16236|ChemicalEntity

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 114-122 OrganismTaxon denotes patients
T2 855-863 OrganismTaxon denotes patients
T3 985-993 OrganismTaxon denotes patients

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T41 2321-2328 ChemicalEntity denotes alcohol ChemicalEntity|http://purl.obolibrary.org/obo/CHEBI_16236|http://purl.obolibrary.org/obo/CHEBI_30879
T39 2307-2320 ChemicalEntity denotes anthracycline http://purl.obolibrary.org/obo/CHEBI_48120|D018943
T37 2192-2205 ChemicalEntity denotes anthracycline http://purl.obolibrary.org/obo/CHEBI_48120|D018943
T35 1963-1976 ChemicalEntity denotes doxorubicinol http://purl.obolibrary.org/obo/CHEBI_133817|C010013
T33 1661-1674 ChemicalEntity denotes anthracycline http://purl.obolibrary.org/obo/CHEBI_48120|D018943
T30 1285-1296 ChemicalEntity denotes doxorubicin http://purl.obolibrary.org/obo/CHEBI_28748|http://purl.obolibrary.org/obo/CHEBI_64816|D004317
T28 1261-1274 ChemicalEntity denotes anthracycline http://purl.obolibrary.org/obo/CHEBI_48120|D018943
T26 1119-1129 ChemicalEntity denotes methionine http://purl.obolibrary.org/obo/CHEBI_16811|http://purl.obolibrary.org/obo/CHEBI_64558
T25 1105-1111 ChemicalEntity denotes valine http://purl.obolibrary.org/obo/CHEBI_27266
T22 940-954 ChemicalEntity denotes anthracyclines http://purl.obolibrary.org/obo/CHEBI_48120|http://purl.obolibrary.org/obo/CHEBI_49322|D018943
T20 753-766 ChemicalEntity denotes anthracycline http://purl.obolibrary.org/obo/CHEBI_48120|D018943
T19 692-710 ChemicalEntity denotes carbonyl reductase D000429
T18 657-671 ChemicalEntity denotes oxidoreductase D010088
T16 618-625 ChemicalEntity denotes adenine http://purl.obolibrary.org/obo/CHEBI_16708|D000225
T14 605-617 ChemicalEntity denotes nicotinamide http://purl.obolibrary.org/obo/CHEBI_17154|D009536
T11 570-584 ChemicalEntity denotes anthracyclines http://purl.obolibrary.org/obo/CHEBI_48120|http://purl.obolibrary.org/obo/CHEBI_49322|D018943
T9 395-408 ChemicalEntity denotes anthracycline http://purl.obolibrary.org/obo/CHEBI_48120|D018943
T6 232-246 ChemicalEntity denotes anthracyclines http://purl.obolibrary.org/obo/CHEBI_48120|http://purl.obolibrary.org/obo/CHEBI_49322|D018943
T4 137-150 ChemicalEntity denotes anthracycline http://purl.obolibrary.org/obo/CHEBI_48120|D018943
T3 84-98 ChemicalEntity denotes oxidoreductase D010088
T2 68-74 ChemicalEntity denotes NAD(P) http://purl.obolibrary.org/obo/CHEBI_25524
T1 29-47 ChemicalEntity denotes carbonyl reductase D000429
T95686 2134-2138 GeneOrGeneProduct denotes CBR3
T24 2060-2064 GeneOrGeneProduct denotes CBR3
T23 2020-2024 GeneOrGeneProduct denotes CBR3
T68344 1999-2003 GeneOrGeneProduct denotes CBR3
T21 1904-1908 GeneOrGeneProduct denotes CBR3
T41939 1771-1775 GeneOrGeneProduct denotes CBR3
T57228 1625-1629 GeneOrGeneProduct denotes NQO1
T50863 1546-1550 GeneOrGeneProduct denotes CBR3
T17 1535-1539 GeneOrGeneProduct denotes NQO1
T48682 1351-1355 GeneOrGeneProduct denotes CBR3
T15 1242-1246 GeneOrGeneProduct denotes CBR3
T87641 1228-1232 GeneOrGeneProduct denotes CBR3
T13 1213-1217 GeneOrGeneProduct denotes CBR3
T12 1100-1104 GeneOrGeneProduct denotes CBR3
T72894 1090-1094 GeneOrGeneProduct denotes CBR3
T10 1078-1082 GeneOrGeneProduct denotes NQO1
T58613 1072-1076 GeneOrGeneProduct denotes NQO1
T8 718-722 GeneOrGeneProduct denotes CBR3
T7 692-712 GeneOrGeneProduct denotes carbonyl reductase 3
T90380 679-683 GeneOrGeneProduct denotes NQO1
T5 657-671 GeneOrGeneProduct denotes oxidoreductase
T11394 106-110 GeneOrGeneProduct denotes NQO1
T14203 68-100 GeneOrGeneProduct denotes NAD(P)H:quinone oxidoreductase 1
T21184 55-59 GeneOrGeneProduct denotes CBR3
T84592 29-49 GeneOrGeneProduct denotes carbonyl reductase 3
T59716 2295-2306 DiseaseOrPhenotypicFeature denotes cardiotoxic D066126
T37170 2234-2240 DiseaseOrPhenotypicFeature denotes cancer D009369
T1373 2214-2217 DiseaseOrPhenotypicFeature denotes CHF D006333
T74026 1951-1962 DiseaseOrPhenotypicFeature denotes cardiotoxic D066126
T47091 1811-1814 DiseaseOrPhenotypicFeature denotes CHF D006333
T71129 1683-1686 DiseaseOrPhenotypicFeature denotes CHF D006333
T25005 1574-1577 DiseaseOrPhenotypicFeature denotes CHF D006333
T76722 999-1002 DiseaseOrPhenotypicFeature denotes CHF D006333
T82642 890-896 DiseaseOrPhenotypicFeature denotes Cancer D009369
T71737 775-778 DiseaseOrPhenotypicFeature denotes CHF D006333
T10819 417-420 DiseaseOrPhenotypicFeature denotes CHF D006333
T78834 343-346 DiseaseOrPhenotypicFeature denotes CHF D006333
T52963 317-341 DiseaseOrPhenotypicFeature denotes congestive heart failure D006333
T46478 258-264 DiseaseOrPhenotypicFeature denotes cancer D009369
T36404 200-206 DiseaseOrPhenotypicFeature denotes cancer D009369
T39650 159-183 DiseaseOrPhenotypicFeature denotes congestive heart failure D006333
T64646 985-993 OrganismTaxon denotes patients
T69553 855-863 OrganismTaxon denotes patients
T49432 114-122 OrganismTaxon denotes patients
T94145 2139-2144 SequenceVariant denotes V244M
T23586 1776-1781 SequenceVariant denotes V244M
T80276 1551-1556 SequenceVariant denotes V244M
T56558 1356-1361 SequenceVariant denotes V244M
T5015 1164-1169 SequenceVariant denotes V244M

DisGeNET

Id Subject Object Predicate Lexical cue
T0 2134-2138 gene:874 denotes CBR3
T1 2214-2217 disease:C0018802 denotes CHF
R1 T0 T1 associated_with CBR3,CHF

DisGeNET5_variant_disease

Id Subject Object Predicate Lexical cue
18457324-11#20#25#geners1056892 2139-2144 geners1056892 denotes V244M
18457324-11#95#98#diseaseC0018802 2214-2217 diseaseC0018802 denotes CHF
18457324-11#105#121#diseaseC0278704 2224-2240 diseaseC0278704 denotes childhood cancer
20#25#geners105689295#98#diseaseC0018802 18457324-11#20#25#geners1056892 18457324-11#95#98#diseaseC0018802 associated_with V244M,CHF
20#25#geners1056892105#121#diseaseC0278704 18457324-11#20#25#geners1056892 18457324-11#105#121#diseaseC0278704 associated_with V244M,childhood cancer

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
18457324-0#29#49#gene874 29-49 gene874 denotes carbonyl reductase 3
18457324-0#55#59#gene874 55-59 gene874 denotes CBR3
18457324-0#76#98#gene1429 76-98 gene1429 denotes quinone oxidoreductase
18457324-0#106#110#gene1728 106-110 gene1728 denotes NQO1
18457324-0#159#183#diseaseC0018802 159-183 diseaseC0018802 denotes congestive heart failure
18457324-0#190#206#diseaseC0278704 190-206 diseaseC0278704 denotes childhood cancer
18457324-0#159#183#diseaseC0018802 159-183 diseaseC0018802 denotes congestive heart failure
18457324-0#190#206#diseaseC0278704 190-206 diseaseC0278704 denotes childhood cancer
18457324-0#159#183#diseaseC0018802 159-183 diseaseC0018802 denotes congestive heart failure
18457324-0#190#206#diseaseC0278704 190-206 diseaseC0278704 denotes childhood cancer
18457324-0#159#183#diseaseC0018802 159-183 diseaseC0018802 denotes congestive heart failure
18457324-0#190#206#diseaseC0278704 190-206 diseaseC0278704 denotes childhood cancer
29#49#gene874159#183#diseaseC0018802 18457324-0#29#49#gene874 18457324-0#159#183#diseaseC0018802 associated_with carbonyl reductase 3,congestive heart failure
29#49#gene874190#206#diseaseC0278704 18457324-0#29#49#gene874 18457324-0#190#206#diseaseC0278704 associated_with carbonyl reductase 3,childhood cancer
29#49#gene874159#183#diseaseC0018802 18457324-0#29#49#gene874 18457324-0#159#183#diseaseC0018802 associated_with carbonyl reductase 3,congestive heart failure
29#49#gene874190#206#diseaseC0278704 18457324-0#29#49#gene874 18457324-0#190#206#diseaseC0278704 associated_with carbonyl reductase 3,childhood cancer
29#49#gene874159#183#diseaseC0018802 18457324-0#29#49#gene874 18457324-0#159#183#diseaseC0018802 associated_with carbonyl reductase 3,congestive heart failure
29#49#gene874190#206#diseaseC0278704 18457324-0#29#49#gene874 18457324-0#190#206#diseaseC0278704 associated_with carbonyl reductase 3,childhood cancer
29#49#gene874159#183#diseaseC0018802 18457324-0#29#49#gene874 18457324-0#159#183#diseaseC0018802 associated_with carbonyl reductase 3,congestive heart failure
29#49#gene874190#206#diseaseC0278704 18457324-0#29#49#gene874 18457324-0#190#206#diseaseC0278704 associated_with carbonyl reductase 3,childhood cancer
55#59#gene874159#183#diseaseC0018802 18457324-0#55#59#gene874 18457324-0#159#183#diseaseC0018802 associated_with CBR3,congestive heart failure
55#59#gene874190#206#diseaseC0278704 18457324-0#55#59#gene874 18457324-0#190#206#diseaseC0278704 associated_with CBR3,childhood cancer
55#59#gene874159#183#diseaseC0018802 18457324-0#55#59#gene874 18457324-0#159#183#diseaseC0018802 associated_with CBR3,congestive heart failure
55#59#gene874190#206#diseaseC0278704 18457324-0#55#59#gene874 18457324-0#190#206#diseaseC0278704 associated_with CBR3,childhood cancer
55#59#gene874159#183#diseaseC0018802 18457324-0#55#59#gene874 18457324-0#159#183#diseaseC0018802 associated_with CBR3,congestive heart failure
55#59#gene874190#206#diseaseC0278704 18457324-0#55#59#gene874 18457324-0#190#206#diseaseC0278704 associated_with CBR3,childhood cancer
55#59#gene874159#183#diseaseC0018802 18457324-0#55#59#gene874 18457324-0#159#183#diseaseC0018802 associated_with CBR3,congestive heart failure
55#59#gene874190#206#diseaseC0278704 18457324-0#55#59#gene874 18457324-0#190#206#diseaseC0278704 associated_with CBR3,childhood cancer
76#98#gene1429159#183#diseaseC0018802 18457324-0#76#98#gene1429 18457324-0#159#183#diseaseC0018802 associated_with quinone oxidoreductase,congestive heart failure
76#98#gene1429190#206#diseaseC0278704 18457324-0#76#98#gene1429 18457324-0#190#206#diseaseC0278704 associated_with quinone oxidoreductase,childhood cancer
76#98#gene1429159#183#diseaseC0018802 18457324-0#76#98#gene1429 18457324-0#159#183#diseaseC0018802 associated_with quinone oxidoreductase,congestive heart failure
76#98#gene1429190#206#diseaseC0278704 18457324-0#76#98#gene1429 18457324-0#190#206#diseaseC0278704 associated_with quinone oxidoreductase,childhood cancer
76#98#gene1429159#183#diseaseC0018802 18457324-0#76#98#gene1429 18457324-0#159#183#diseaseC0018802 associated_with quinone oxidoreductase,congestive heart failure
76#98#gene1429190#206#diseaseC0278704 18457324-0#76#98#gene1429 18457324-0#190#206#diseaseC0278704 associated_with quinone oxidoreductase,childhood cancer
76#98#gene1429159#183#diseaseC0018802 18457324-0#76#98#gene1429 18457324-0#159#183#diseaseC0018802 associated_with quinone oxidoreductase,congestive heart failure
76#98#gene1429190#206#diseaseC0278704 18457324-0#76#98#gene1429 18457324-0#190#206#diseaseC0278704 associated_with quinone oxidoreductase,childhood cancer
106#110#gene1728159#183#diseaseC0018802 18457324-0#106#110#gene1728 18457324-0#159#183#diseaseC0018802 associated_with NQO1,congestive heart failure
106#110#gene1728190#206#diseaseC0278704 18457324-0#106#110#gene1728 18457324-0#190#206#diseaseC0278704 associated_with NQO1,childhood cancer
106#110#gene1728159#183#diseaseC0018802 18457324-0#106#110#gene1728 18457324-0#159#183#diseaseC0018802 associated_with NQO1,congestive heart failure
106#110#gene1728190#206#diseaseC0278704 18457324-0#106#110#gene1728 18457324-0#190#206#diseaseC0278704 associated_with NQO1,childhood cancer
106#110#gene1728159#183#diseaseC0018802 18457324-0#106#110#gene1728 18457324-0#159#183#diseaseC0018802 associated_with NQO1,congestive heart failure
106#110#gene1728190#206#diseaseC0278704 18457324-0#106#110#gene1728 18457324-0#190#206#diseaseC0278704 associated_with NQO1,childhood cancer
106#110#gene1728159#183#diseaseC0018802 18457324-0#106#110#gene1728 18457324-0#159#183#diseaseC0018802 associated_with NQO1,congestive heart failure
106#110#gene1728190#206#diseaseC0278704 18457324-0#106#110#gene1728 18457324-0#190#206#diseaseC0278704 associated_with NQO1,childhood cancer

tmVarCorpus

Id Subject Object Predicate Lexical cue
T1 1164-1169 ProteinMutation:p|SUB|V|244|M denotes V244M
T2 1356-1361 ProteinMutation:p|SUB|V|244|M denotes V244M
T3 1551-1556 ProteinMutation:p|SUB|V|244|M denotes V244M
T4 1776-1781 ProteinMutation:p|SUB|V|244|M denotes V244M
T5 2139-2144 ProteinMutation:p|SUB|V|244|M denotes V244M